随着中国加入WTO,我国将在更大范围开放和更深程度上参与国际经济合作与分工,这意味着中国必须遵循市场经济的规则。因此,修改过去在计划经济体制下和向市场经济转型期所制订的并不适应市场经济和WTO要求的行政法规及规则,正在我国行政部门内广泛开展。 但在医药行业,问题却并不简单。由于药品的特殊性,按照《药品管理法》的规定及行业特点,医药行业一直处于政府的 With China’s accession to the WTO, our country will participate in international economic cooperation and division of labor on a wider scope and at a deeper level, which means that China must abide by the rules of a market economy. Therefore, the revision of the administrative rules and regulations formulated in the past under the planned economic system and the transition to a market economy that are not suited to the requirements of a market economy and the WTO are being extensively carried out in our administrative departments. But in the pharmaceutical industry, the problem is not simple. Due to the particularity of the drugs, according to the provisions of the Drug Administration Law and the characteristics of the industry, the pharmaceutical industry has always been in the government’s